Novanta to Present at the Baird 2017 Global Industrial Conference
Get Alerts NOVT Hot Sheet
Join SI Premium – FREE
BEDFORD, Mass., Oct. 23, 2017 /PRNewswire/ -- Novanta Inc. (NASDAQ: NOVT) (the "Company" or "Novanta"), a trusted technology partner to medical and advanced technology equipment manufacturers, today announced that Matthijs Glastra, Chief Executive Officer, and Robert Buckley, Chief Financial Officer, will present at the Baird 2017 Global Industrial Conference to be held at the Four Seasons Hotel in Chicago, Illinois. The Company's presentation will be on Wednesday, November 8, 2017 at 1:00 p.m. CT (2:00 p.m. ET).
An audio webcast of the presentation will be available on the Investor Relations section of the Company's website at www.novanta.com.
About Novanta
Novanta is a leading global supplier of core technology solutions that give healthcare and advanced industrial original equipment manufacturers ("OEMs") a competitive advantage. We combine deep proprietary technology expertise in photonics, vision, and precision motion with a proven ability to solve complex technical challenges. This enables Novanta to engineer core components and sub-systems that deliver extreme precision and performance, tailored to our customers' demanding applications. The driving force behind our growth is the team of innovative professionals who share a commitment to innovation and customer success. Novanta's common shares are quoted on NASDAQ under the ticker symbol "NOVT."
More information about Novanta is available on the Company's website at www.novanta.com. For additional information, please contact Novanta Inc. Investor Relations at (781) 266-5137 or [email protected].
Novanta Inc. Investor Relations Contact: Robert J. Buckley(781) 266-5137

View original content with multimedia:http://www.prnewswire.com/news-releases/novanta-to-present-at-the-baird-2017-global-industrial-conference-300541451.html
SOURCE Novanta Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Omnis Energy: Judge Disqualifies HSF Kramer from Representing Pleasants Power Station in Bankruptcy Case
- Scholar Rock Announces FDA Approval of ISEMBYLD™ (apitegromab-mstn), the First and Only Muscle-Targeted Treatment for Children and Adults with Spinal Muscular Atrophy (SMA)
- EagleOne Metals Announces Closing of Private Placement
Create E-mail Alert Related Categories
Press ReleasesRelated Entities
Robert W BairdSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share